Medicine and Dentistry
Major Depressive Episode
100%
Adolescence
98%
Depression
74%
Inflammation
41%
C Reactive Protein
37%
Depression of Adolescent
35%
Systematic Review
33%
Patient with Depression
33%
Biological Marker
31%
Patient
31%
Hydrocortisone
24%
Association
22%
Marker
22%
Female
21%
Follow up
21%
Therapeutic Procedure
21%
Immunity
20%
Male
20%
Adolescent Depression
18%
Stress
18%
Immune System
16%
Minocycline
16%
Treatment Resistant Depression
16%
Endocannabinoid System
16%
Meta-Analysis
16%
Pediatric Trauma
16%
Adulthood
16%
Sex Hormone
16%
Randomized Clinical Trial
16%
Low and Middle Income Countries
11%
Brain Abnormalities
10%
Glucocorticoid
9%
Adult
9%
Girl
8%
Treatment Response
7%
Analysis
7%
Cross Sectional Study
6%
Diagnosis
6%
Placebo
6%
Pathophysiology
5%
Global Health
5%
Young Adult
5%
Hypothalamic-Pituitary-Adrenal Axis
5%
Disease
5%
Neuroscience
Major Depressive Disorder
98%
Endocannabinoid
39%
Minocycline
33%
Interferon
33%
Heart Rate Variability
33%
Autonomic Nervous System
33%
Treatment-Resistant Depression
33%
Antidepressant
25%
Kynurenine
23%
C-Reactive Protein
18%
Nervous System
18%
Anterior Cingulate Cortex
17%
Emotion
16%
2-Arachidonoylglycerol
16%
Pediatric Trauma
16%
Body Mass Index
16%
Alpha Interferon A
16%
Depression
16%
Anti-Inflammatory
16%
Brain
15%
Mood Disorder
11%
Anxiety
11%
Glucocorticoid
8%
Cortisol
6%
Interleukin 6
6%
Mental Disorder
5%
Psychology
Systematic Review
67%
Meta-Analysis
35%
Depression
27%
Neurological System
20%
Critical Review
16%
Emotion
16%
Mood Disorder
13%
Parasympathetic Activity
13%
Methodology
10%
Psychiatric Disorder
10%
Physical Health
8%
Mood
7%
Patient with Depression
7%
Sympathetic Nervous System
6%
